RNA Therapeutics Markets, 2035 - Technical and Financial Perspective on How the Opportunity in this Domain is Likely to Evolve
24 avr. 2023 03h33 HE
|
Research and Markets
Dublin, April 24, 2023 (GLOBE NEWSWIRE) -- The "Investor Series: Opportunities in RNA Therapeutics Market" report has been added to ResearchAndMarkets.com's offering. The Investor Series:...
Global NGS-Based RNA-Sequencing Market Report 2023: Growth in Precision Medicine is Fuelling the Sector
18 avr. 2023 12h13 HE
|
Research and Markets
Dublin, April 18, 2023 (GLOBE NEWSWIRE) -- The "NGS-Based RNA-Sequencing Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
Global Cloning & Mutagenesis Market Report 2023: Increasing Research and Development Activities in Cancer and Other Chronic Disorders Fuels Growth
18 avr. 2023 11h58 HE
|
Research and Markets
Dublin, April 18, 2023 (GLOBE NEWSWIRE) -- The "Cloning & Mutagenesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Gene Type (Standard v/s...
United Kingdom Cell & Gene Therapy Business and Investment Opportunities Databook - Q1 2023 Update
14 avr. 2023 07h33 HE
|
Research and Markets
Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "United Kingdom Cell & Gene Therapy Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ...
Exosome Therapeutics Global Market Report 2023: Multifunctional Properties for the Treatment of Cancer, Alzheimer's, Parkinson's and Heart Failure Drives Adoption
13 avr. 2023 06h43 HE
|
Research and Markets
Dublin, April 13, 2023 (GLOBE NEWSWIRE) -- The "Exosome Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Exosome Type (Natural v/s...
Global Epigenetics Market Report 2023: Rising Prevalence of Cancer and Other Diseases Drives Growth
12 avr. 2023 11h48 HE
|
Research and Markets
Dublin, April 12, 2023 (GLOBE NEWSWIRE) -- The "Epigenetics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and...
SiSaf Appoints Dr. Richard Goodfellow to Board of Directors
05 avr. 2023 03h00 HE
|
SiSaf Ltd
GUILDFORD, England, April 05, 2023 (GLOBE NEWSWIRE) -- RNA delivery and therapeutics company SiSaf Ltd today announced that it has appointed Dr. Richard Goodfellow to its Board of Directors. ...
Global RNA Analysis/Transcriptomics Market Report 2023: Increasing Demand for Personalized Medicine is Expected to Drive Growth
31 mars 2023 07h53 HE
|
Research and Markets
Dublin, March 31, 2023 (GLOBE NEWSWIRE) -- The "RNA Analysis/Transcriptomics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line
30 mars 2023 16h05 HE
|
GreenLight Biosciences
BOSTON, March 30, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA) (“GreenLight” or the “Company”), a public benefit corporation striving to deliver on the full potential of RNA to...
GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results
28 mars 2023 17h05 HE
|
GreenLight Biosciences
Two agriculture solutions now under regulatory review, pending EPA approval: Calantha™, a solution to protect potatoes, and a separate solution to protect honeybees from Varroa miteUpdated clinical...